Marc Lasry’s Hoops & Holdings, Alzheimer’s Drug Approved, & Ransomware, Beware

Squawk Pod

CNBC

Business News, News, Investing, Business

4.2 • 543 Ratings

🗓️ 8 June 2021

⏱️ 34 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Billionaire businessman and hedge funder Marc Lasry breaks down his outlook for the Federal Reserve, meme stock mania, and the bitcoin roller coaster of 2021. Lasry, a co-owner of the Milwaukee Bucks, weighs pros and cons of getting back in the game for the Olympics--either his players, or himself. Former NYSE President and Chairman of Far Peak Thomas Farley talks basketball and interest rates with Lasry, Becky, and Andrew. The FDA has approved the first Alzheimer’s drug in nearly two decades, but Biogen faces tough questions from investors about the drug and its pricing. CNBC’s Meg Tirrell and CFRA Analyst Kevin Huang break down Wall Street’s concerns about the drugmaker’s next steps. Plus, Apple is out with new gadgets and features, President Biden is unkinking the supply chain, and hackers, hacked: the U.S. government is headed for the Darkside Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Transcript

Click on a timestamp to play from that location

0:00.0	Bring in show music please.
0:03.0	This is Squawk Pod.
0:05.0	I'm C. NBC producer Katie Kramer.
0:07.0	Today on our podcast,
0:09.0	The Memes, the Fed, and the Bitcoin roller coaster with billionaire investor Mark Lassary.
0:14.4	As more and more people keep using Bitcoin, it's going to keep moving up.
0:18.1	It's happened a little bit quicker than I thought it would. I should have bought a lot more.
0:21.5	That was my mistake. Where he's putting his money to work
0:24.9	despite the unknown right now the feds in a little bit of a box at least for the next year or two I don't
0:30.3	know what happens you know a couple years from now,
0:33.0	but at least for the next year or two,
0:34.6	you want to be an investor.
0:36.5	And the FDA approves the first Alzheimer's drug
0:39.4	in decades, but the cost and efficacy are concerns.
0:42.6	Biotech analyst Kevin Huang.
0:44.3	There's only 18,000 neurologists in the US,
0:47.0	whereas there's over 5 million patients
0:49.1	who might be treatable by Adukanumab.
0:52.2	Those stories, plus Apple is out with a slew of new features for techies.
0:56.0	The president is out with a plan to clear the supply chain bottlenecks and ransomware,
1:00.0	beware the U.S. government can hack you back.
1:03.0	So maybe the vault was safe, but what was around the vault? Not so safe?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.